Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares saw strong trading volume on Monday . 476,808 shares were traded during trading, an increase of 980% from the previous session's volume of 44,138 shares.The stock last traded at $5.05 and had previously closed at $5.03.
Hypermarcas Price Performance
The stock has a 50 day moving average of $4.46 and a two-hundred day moving average of $3.70. The stock has a market cap of $3.18 billion, a PE ratio of 20.91 and a beta of 0.81. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26.
Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.04) EPS for the quarter. The business had revenue of $184.34 million during the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%.
Hypermarcas Dividend Announcement
The business also recently disclosed a dividend, which will be paid on Friday, January 8th. Shareholders of record on Tuesday, July 1st will be issued a $0.0345 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a yield of 2.81%. Hypermarcas's dividend payout ratio is presently 58.33%.
Hypermarcas Company Profile
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Stories
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
